Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
4.030
+0.070 (1.77%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Stock Forecast
PHAT's stock price has decreased by -55.27% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Phathom Pharmaceuticals stock have an average target of 22.5, with a low estimate of 10 and a high estimate of 28. The average target predicts an increase of 458.31% from the current stock price of 4.03.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Phathom Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +594.79% | Apr 21, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +148.14% | Apr 17, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +594.79% | Apr 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Apr 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +594.79% | Apr 2, 2025 |
Financial Forecast
Revenue This Year
166.99M
from 55.25M
Increased by 202.23%
Revenue Next Year
357.04M
from 166.99M
Increased by 113.81%
EPS This Year
-4.33
from -5.29
EPS Next Year
-2.15
from -4.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 180.6M | 400.2M | 751.5M | ||
| Avg | 167.0M | 357.0M | 603.7M | ||
| Low | 145.7M | 319.9M | 507.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 226.9% | 139.6% | 110.5% | ||
| Avg | 202.2% | 113.8% | 69.1% | ||
| Low | 163.8% | 91.6% | 42.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -4.01 | -1.48 | 1.16 | ||
| Avg | -4.33 | -2.15 | 0.18 | ||
| Low | -4.61 | -3.01 | -0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.